Blood And Tears in Alzheimer's Disease
Recruiting · NCT06567431 · Observational (researchers observe without assigning treatment) · Lead sponsor: Danish Dementia Research Centre
View the official record on ClinicalTrials.gov →What this trial is about
This study aims to investigate whether biomarkers of Alzheimer's disease can be found in tearfluid, as well as dried bloodspots in patients with Alzheimer's disease, other dementia diagnoses compared to controls.
Who can take part
Age range
30 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Inclusion criteria for patients:
- Lumbar puncture with CSF avaiable for analysis
- Diagnosis of Alzheimer's disease, Dementia with Lewy Bodies (DLB), Frontotemporal dementia (FTD), vascular dementia (VaD) or Normal pressure hydrocephalus (NPH)
- Of legal age.
- Inclusion criteria for controls:
- Lumbar puncture with CSF avaiable for analysis
- No neurological disease.
- Of legal age.
Exclusion criteria
- No lumbar puncture
- Clinically assessed as unfit to participate in the project.
Where it is running
1 location listed.
- Danish Dementia Research Centre - Copenhagen, Denmark